These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34811632)

  • 1. The matricellular protein CCN6 differentially regulates mitochondrial metabolism in normal epithelium and in metaplastic breast carcinomas.
    Tran M; Leflein SA; Gonzalez ME; Kleer CG
    J Cell Commun Signal; 2022 Sep; 16(3):433-445. PubMed ID: 34811632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas.
    Martin EE; Huang W; Anwar T; Arellano-Garcia C; Burman B; Guan JL; Gonzalez ME; Kleer CG
    Oncogene; 2017 Apr; 36(16):2275-2285. PubMed ID: 27819674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCN6 regulates IGF2BP2 and HMGA2 signaling in metaplastic carcinomas of the breast.
    McMullen ER; Gonzalez ME; Skala SL; Tran M; Thomas D; Djomehri SI; Burman B; Kidwell KM; Kleer CG
    Breast Cancer Res Treat; 2018 Dec; 172(3):577-586. PubMed ID: 30220054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas.
    Tran MN; Kleer CG
    J Cell Commun Signal; 2018 Mar; 12(1):13-19. PubMed ID: 29357008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The matricellular protein CCN6 (WISP3) decreases Notch1 and suppresses breast cancer initiating cells.
    Huang W; Martin EE; Burman B; Gonzalez ME; Kleer CG
    Oncotarget; 2016 May; 7(18):25180-93. PubMed ID: 26933820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of CCN6 (WISP3) activates growth factor-independent survival and resistance to anoikis in human mammary epithelial cells.
    Huang W; Gonzalez ME; Toy KA; Banerjee M; Kleer CG
    Cancer Res; 2010 Apr; 70(8):3340-50. PubMed ID: 20395207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer.
    Lorenzatti G; Huang W; Pal A; Cabanillas AM; Kleer CG
    J Cell Sci; 2011 May; 124(Pt 10):1752-8. PubMed ID: 21525039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metaplastic Breast Carcinoma: Update on Histopathology and Molecular Alterations.
    McMullen ER; Zoumberos NA; Kleer CG
    Arch Pathol Lab Med; 2019 Dec; 143(12):1492-1496. PubMed ID: 31765246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells.
    Zhang Y; Pan Q; Zhong H; Merajver SD; Kleer CG
    Breast Cancer Res; 2005; 7(6):R1080-9. PubMed ID: 16457688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors.
    Djomehri SI; Gonzalez ME; da Veiga Leprevost F; Tekula SR; Chang HY; White MJ; Cimino-Mathews A; Burman B; Basrur V; Argani P; Nesvizhskii AI; Kleer CG
    Nat Commun; 2020 Apr; 11(1):1723. PubMed ID: 32265444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1.
    Huang W; Zhang Y; Varambally S; Chinnaiyan AM; Banerjee M; Merajver SD; Kleer CG
    Am J Pathol; 2008 Apr; 172(4):893-904. PubMed ID: 18321996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCN6 modulates BMP signaling via the Smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer.
    Pal A; Huang W; Li X; Toy KA; Nikolovska-Coleska Z; Kleer CG
    Cancer Res; 2012 Sep; 72(18):4818-28. PubMed ID: 22805309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCN6 regulates mitochondrial function.
    Patra M; Mahata SK; Padhan DK; Sen M
    J Cell Sci; 2016 Jul; 129(14):2841-51. PubMed ID: 27252383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer.
    Kleer CG; Zhang Y; Merajver SD
    Cells Tissues Organs; 2007; 185(1-3):95-9. PubMed ID: 17587813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCN6: a modulator of breast cancer progression.
    Leask A
    J Cell Commun Signal; 2016 Jun; 10(2):163-4. PubMed ID: 27086280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCN6 (WISP3): a new anti-cancer therapy?
    Leask A
    J Cell Commun Signal; 2010 Dec; 4(4):199-200. PubMed ID: 21234127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer.
    Djomehri SI; Burman B; Gonzalez ME; Takayama S; Kleer CG
    J Cell Commun Signal; 2019 Mar; 13(1):129-143. PubMed ID: 30515709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCN6 knockdown disrupts acinar organization of breast cells in three-dimensional cultures through up-regulation of type III TGF-β receptor.
    Pal A; Huang W; Toy KA; Kleer CG
    Neoplasia; 2012 Nov; 14(11):1067-74. PubMed ID: 23226100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma.
    González-Martínez S; Pérez-Mies B; Carretero-Barrio I; Palacios-Berraquero ML; Perez-García J; Cortés J; Palacios J
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32650408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100a4 upregulation in Pik3caH1047R;Trp53R270H;MMTV-Cre-driven mammary tumors promotes metastasis.
    Yuan W; Goldstein LD; Durinck S; Chen YJ; Nguyen TT; Kljavin NM; Sokol ES; Stawiski EW; Haley B; Ziai J; Modrusan Z; Seshagiri S
    Breast Cancer Res; 2019 Dec; 21(1):152. PubMed ID: 31881983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.